Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327623 · ClinicalTrials.gov registry record
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 290
- Enrollment target
NCT03327623: Completed study, sponsored by Mayo Clinic.
NCT03327623 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03327623 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if its presence is associated with changes in the functioning of the body. The investigators want to determine if sleep apnea is associated with electrical disorders of the heart in patients with hypertrophic cardiomyopathy.
Primary Outcome
Measured by the Apnea-hypopnea index (AHI). The AHI is the number of apneas or hypopneas recorded during the study per hour of sleep. It is generally expressed as the number of events per hour. Based on the AHI, sleep apnea is diagnosed if an AHI ≥5 events/hour.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2024-06-21 |
What the finished NCT03327623 record still lists
NCT03327623 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03327623 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03327623 about?
NCT03327623 is a clinical study titled "Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)". The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if its presence is associated with changes in the functioning of the body. The investigators want to dete...
What is the current status of trial NCT03327623?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2017-11-13. Estimated completion is 2024-06-21.
Who is sponsoring clinical trial NCT03327623?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI